The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...
The challenge of maintaining the earlier growth achieved by US mRNA medicines specialist Moderna through its COVID vaccine ...
Hosted on MSN1mon
Moderna CEO says he'll work with Trump using 'facts and data'Moderna (MRNA) CEO Stéphane Bancel said that he plans to address any partisan hurdles with the incoming Trump administration’s vaccine and pandemic preparedness policies with “facts and data.” ...
“We’ve worked with several administrations, including President Trump and his team,” Moderna CEO Stéphane Bancel told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback